Polymers, encapsulation, and artificial organs (report on session 26.0). Washington D.C., July 15, 1992.
Sanberg
P R
PR
Department of Surgery, University of South Florida College of Medicine, Tampa 33612-4799.
Freeman
T B
TB
Cahill
D W
DW
D000544:Alzheimer Disease / Q000628:therapy; D000818:Animals; D000978:Antiparkinson Agents / Q000008:administration & dosage; D001187:Artificial Organs; D017690:Cell Transplantation / Q000379:methods*; D004339:Drug Compounding; D004343:Drug Implants; D005347:Fibroblasts / Q000378:metabolism / Q000637:transplantation; D005782:Gels; D005818:Genetic Engineering; D006801:Humans; D009414:Nerve Growth Factors / Q000008:administration & dosage; D009416:Nerve Regeneration / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy / Q000601:surgery; D014677:Pharmaceutical Vehicles; D011108:Polymers; D051381:Rats; D012583:Schwann Cells / Q000637:transplantation
D000978:Antiparkinson Agents; D004343:Drug Implants; D005782:Gels; D009414:Nerve Growth Factors; D014677:Pharmaceutical Vehicles; D011108:Polymers